ArticleFrontiers in endocrinology2025
Global temporal trends and predictions in the burden of chronic kidney disease attributable to diet high in sugar-sweetened beverages: an age-period-cohort analysis for GBD 2021.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to evaluate temporal trends in chronic kidney disease (CKD) mortality attributable to excessive sugar-sweetened beverage (SSB) intake globally from 1990 to 2021 and to forecast future trends until 2040. Methods: Utilizing the Global Burden of Disease (GBD) 2021 dataset, we focused on the temporal trends in SSB-related CKD mortality. An age-period-cohort (APC) model was employed to analyze mortality trends by age, period, and cohort. Results: In 2021, the deaths attributable to SSB-related CKD were particularly elevated in high and middle sociodemographic index (SDI) regions. Among the countries studied, 62 had at least one million deaths in 2021, with the USA, Mexico, China, India, and Brazil being the top five. From 1990 to 2021, the net drift of SSB-related CKD mortality ranged from 0.54% (95% UI: -0.72 to 1.81) in low SDI regions to 3.83% (95% UI: 3.40 to 4.27) in high SDI regions. Local drift estimates indicated elevated mortality across all age groups. Globally, the increasing mortality of SSB-related CKD shifted towards the older population. Age effects showed a similar trend across all SDI regions, and the risk increased with age. Period effects for low-middle, middle, high-middle, and high SDI regions showed an improving trend before 2004, but an adverse trend after 2004. Low-middle, middle, and high SDI regions showed unfavorable trends in successive cohorts. Projections indicate a continuous increase in global deaths from SSB-related CKD over the next two decades. Conclusion: This study is the first to investigate the global temporal trends in the burden of SSB-related CKD. Over the past three decades, mortality from SSB-related CKD has demonstrated a generally upward trajectory. Evidence-based public health interventions and policies targeting SSB consumption and CKD management are imperative in high-burden regions to mitigate the advancing impact of SSB-related CKD on public health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.